Principal Investigator Clark Colton
Co-investigator Robert Fisher
One major issue preventing wide scale application of islet transplantation is the permanent use of immunosuppressive agents. Microencapsulation provides transplanted islets with protection from aspects of immune rejection. However, the microcapsule prevents islet revascularization and creates an additional resistance for oxygen transport to islets.